Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now official registry

Infant, Premature clinical trials

Every US clinical trial registered for Infant, Premature — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

14 US clinical trials · 2 currently recruiting

The research picture

Infant, Premature has 14 registered US clinical trials, 2 of them open to new participants right now — about 14% of the total.

2
recruiting participants now
14%
of trials open to enrollment
3
in Phase 3–4 (later-stage)
12
top sponsor: NICHD Neonatal Research Network

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING 80,000 participants

Generic Database of Very Low Birth Weight Infants

NICHD Neonatal Research Network

NCT00063063

RECRUITING 68,000 participants

Follow-up Visit of High Risk Infants

NICHD Neonatal Research Network

NCT00009633

ACTIVE NOT RECRUITING Phase 3 836 participants

Management of the PDA Trial

NICHD Neonatal Research Network

NCT03456336

COMPLETED Phase 2 2,416 participants

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

NICHD Neonatal Research Network

NCT01203345

COMPLETED Phase 3 1,433 participants

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

NICHD Neonatal Research Network

NCT00005775

COMPLETED 1,339 participants

In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants

NICHD Neonatal Research Network

NCT01203501

COMPLETED 1,090 participants

Development of Standards for the New Ballard Maturation Score

NICHD Neonatal Research Network

NCT01203449

COMPLETED 1,067 participants

Inflammatory Cytokines Associated With Perinatal Brain Injury

NICHD Neonatal Research Network

NCT01035697

COMPLETED Phase 3 800 participants

Hydrocortisone for BPD

NICHD Neonatal Research Network

NCT01353313

COMPLETED 410 participants

Physiologic Definition of Bronchopulmonary Dysplasia

NICHD Neonatal Research Network

NCT01223287

COMPLETED NA 226 participants

Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates

University of Texas Southwestern Medical Center

NCT02064712

COMPLETED Phase 1 104 participants

Delivery Room CPAP in Extremely Low Birth Weight Infants

NICHD Neonatal Research Network

NCT01223274

COMPLETED 102 participants

Cerebral Function Monitoring in Premature Infants

NICHD Neonatal Research Network

NCT00873847

COMPLETED 64 participants

Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus

University of Utah

NCT03551600

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 3

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Infant, Premature Trial Landscape

ClinicalTrials.gov lists 14 US studies indexed under Infant, Premature, and 2 of those are currently open to recruitment — roughly 14% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Infant, Premature shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Infant, Premature is led by NICHD Neonatal Research Network with 12 indexed trials, alongside 2 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Infant, Premature?

PlainTrial tracks 14 US clinical trials for Infant, Premature, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Infant, Premature?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →